Study leads Shilpa Venkatachalam, MD, and Michael George, MD, discuss the highlights of a new initiative to track the effects of COVID-19 in autoimmune disorders.
A EULAR task force developed recommendations for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy.
Expertscape is a digital physician ranking and search tool that helps both patients and referring physicians easily locate experts in numerous specialties.
Nonpharmacologic management of fatigue in rheumatoid arthritis may alter causal pathways of fatigue and provide significant benefits.
Experts have advised the evaluation of spondyloarthritis in patients with inflammatory bowel disease.
Recent reports have indicated an association between a Kawasaki-like disease and COVID-19 in pediatric populations. Mary Beth Son, MD, of the Boston Children’s Hospital weighs in.
Hydroxychloroquine is a less-toxic metabolite of the antimalarial drug chloroquine and is used as an immunomodulator for the treatment of autoimmune diseases.
The relationship between lung cancer and rheumatoid arthritis remains an active topic of research, as more information is needed regarding their association.
Seven things to consider when transitioning to telemedicine during the COVID-19 pandemic.
What are the top 3 things that rheumatologists need to know about vaccines in rheumatic diseases?